Tuesday, July 21, 2020 1:11:57 PM
Anytime. Ive done a hours upon hours of reading and calculating. Imo, $SBFM is lifestyle changer.
Clean OS with a whole lot of research, years and years worth, to support the patent.
In my honest opinion, this thing has buy-out written all over it.
Patent filing should have brought funding news. No funding needed if your selling, right? Look at all the money being handed out for a cure.
Years of proven research.... Nobody wanted it to short cut the hundreds of millions of dollars needed to get back to where $SBFM left off? Maybe, if you hit the target like they did? That's a big gamble. As a business owner, that doesnt make since, when the timeline on this one matters. The shortest timeline wins big.
Canada announces they're wanting an "in-country" cure less a few weeks after the patent filing, and only blocks down the road from SBFM?
I could go on and on... but you get the point.
Just my opion.
Clean OS with a whole lot of research, years and years worth, to support the patent.
In my honest opinion, this thing has buy-out written all over it.
Patent filing should have brought funding news. No funding needed if your selling, right? Look at all the money being handed out for a cure.
Years of proven research.... Nobody wanted it to short cut the hundreds of millions of dollars needed to get back to where $SBFM left off? Maybe, if you hit the target like they did? That's a big gamble. As a business owner, that doesnt make since, when the timeline on this one matters. The shortest timeline wins big.
Canada announces they're wanting an "in-country" cure less a few weeks after the patent filing, and only blocks down the road from SBFM?
I could go on and on... but you get the point.
Just my opion.
Recent SBFM News
- Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year • ACCESS Newswire • 04/06/2026 12:30:00 PM
- Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea • ACCESS Newswire • 10/28/2025 11:45:00 AM
- Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline • ACCESS Newswire • 10/20/2025 11:45:00 AM
- Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin • ACCESS Newswire • 10/16/2025 11:45:00 AM
- Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience • ACCESS Newswire • 10/14/2025 11:00:00 AM
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections • ACCESS Newswire • 10/09/2025 12:00:00 PM
